Literature DB >> 10360805

Validity of two scales in identifying HIV-associated dementia.

J P Berghuis1, K K Uldall, B Lalonde.   

Abstract

OBJECTIVES: To examine and compare the validity of the HIV Dementia Scale (HDS) and Executive Interview (EXIT) in detecting HIV/AIDS dementia.
METHODS: The sample included hospitalized or skilled nursing/assisted-living facility (SNF) HIV/AIDS patients (N = 103). Participants completed the HDS, EXIT, and the Structured Clinical Interview from the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). A chart review also was performed.
RESULTS: Sample was predominantly male (93%) and white (79%), with a mean age of 38 years (standard deviation [SD] = 8 years). Twelve patients had a clinical diagnosis of HIV dementia. Cutoff scores of 10 or less for the HDS and 11 or more for the EXIT optimized sensitivity and specificity. Education level was related to performance for both tests. Using separate logistic regression analyses, the HDS and the EXIT were significant individual predictors of dementia. When entered together, the EXIT was the only significant predictor of dementia. Selected items of the HDS and EXIT also performed well in identifying patients with dementia.
CONCLUSIONS: The HDS and the EXIT show promise as brief, well-tolerated screening tools for HIV dementia in ill patients. The HDS was more sensitive, but the EXIT added additional predictive power over the HDS in identifying dementia.

Entities:  

Mesh:

Year:  1999        PMID: 10360805

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  16 in total

1.  Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa.

Authors:  Karl Goodkin; David J Hardy; Dinesh Singh; Enrique Lopez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

2.  Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.

Authors:  Albert M Anderson; Jeffrey L Lennox; Minh L Nguyen; Drenna Waldrop-Valverde; William R Tyor; David W Loring
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

Review 3.  Screening for cognitive impairment in human immunodeficiency virus.

Authors:  Victor Valcour; Robert Paul; Stephanie Chiao; Lauren A Wendelken; Bruce Miller
Journal:  Clin Infect Dis       Date:  2011-10       Impact factor: 9.079

Review 4.  Clinical management of psychiatric disorders in patients with HIV disease.

Authors:  Eugene W Farber; J Stephen McDaniel
Journal:  Psychiatr Q       Date:  2002

5.  Normative scores for a brief neuropsychological battery for the detection of HIV-associated neurocognitive disorder (HAND) among South Africans.

Authors:  Dinesh Singh; John A Joska; Karl Goodkin; Enrique Lopez; Landon Myer; Robert H Paul; Sally John; Henry Sunpath
Journal:  BMC Res Notes       Date:  2010-01-29

6.  Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale.

Authors:  Erin E Morgan; Steven Paul Woods; J Cobb Scott; Meredith Childers; Jennifer Marquie Beck; Ronald J Ellis; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2007-04-20       Impact factor: 2.475

7.  Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort.

Authors:  Maiko Sakamoto; Thomas D Marcotte; Anya Umlauf; Donald Franklin; Robert K Heaton; Ronald J Ellis; Scott Letendre; Terry Alexander; J A McCutchan; Erin E Morgan; Steven P Woods; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David Simpson; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2013-01-01       Impact factor: 3.731

8.  Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program.

Authors: 
Journal:  Clin Infect Dis       Date:  2012-11-21       Impact factor: 9.079

9.  Disclosing HIV serostatus to family members: Effects on psychological and physiological health in minority women living with HIV.

Authors:  Erin M Fekete; Michael H Antoni; Ron Durán; Brenda L Stoelb; Mahendra Kumar; Neil Schneiderman
Journal:  Int J Behav Med       Date:  2009

10.  Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment.

Authors:  Stephen L Aita; Quanhathai Kaewpoowat; Saowaluck Yasri; Amaraporn Rerkasem; Kittipan Rerkasem; Janejit Choovuthayakorn; Somsanguan Ausayakhun; Kevin Robertson; Robert M Roth; Nathaniel M Robbins
Journal:  J Neurovirol       Date:  2021-06-29       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.